Last week, Aimed Alliance Director of Public Policy, Stacey L. Worthy, was quoted in an article in California Healthline, entitled Amid Growing Rx Costs, No Consensus on Addressing Access. The article notes that discussions about cost need to address spending across the entire health care system to ensure access to high quality, patient-centered care. As such, calls for pharmaceutical industry-wide price controls are inappropriate. Ms. Worthy notes that “[p]rice controls for the entire pharmaceutical industry would interfere with supply and demand and there would be less funding for research and development.” The full article is available here.
Last Updated on May 7, 2020 by Aimed Alliance
